Literature DB >> 30409689

The Evolution of Mammography Controversy in the News Media: A Content Analysis of Four Publicized Screening Recommendations, 2009 to 2016.

Rebekah H Nagler1, Erika Franklin Fowler2, Nora M Marino3, Kari McClure Mentzer4, Sarah E Gollust4.   

Abstract

BACKGROUND: There is longstanding expert disagreement about the age at and frequency with which women should be screened for breast cancer. These debates are reflected in the conflicting recommendations about mammography issued by major professional organizations, such as the U.S. Preventive Services Task Force and the American Cancer Society. Previous research has shown that these recommendations garner substantial media attention-and therefore might affect women's screening perceptions and behaviors-but to date analyses of such media coverage have focused on single publicized announcements.
METHODS: To assess whether media coverage of mammography screening recommendations has evolved, we conducted a content analysis of televised news from four discrete media events from 2009 to 2016, all of which focused on publicized screening recommendations from the U.S. Preventive Services Task Force and American Cancer Society (N = 364 stories).
RESULTS: Media coverage of mammography screening recommendations has featured persistent messages of conflict and/or controversy over time. The evolution of controversy was also reflected in shifts in the relative attention given to mammography screening's risks and benefits, with consistent and, in some cases, heightened attention to screening's risks during more recent media events. Overall, the accuracy of media coverage improved over time.
CONCLUSIONS: Results underscore the continued prevalence of conflicting and/or controversial information about mammography screening in the public information environment. Cumulative exposure to such messages could influence women's decision making around screening and trust in cancer prevention recommendations. Strategies are needed to better equip all women (and particularly underserved women) to negotiate mammography controversy and weigh the benefits and risks of screening.
Copyright © 2018 Jacobs Institute of Women's Health. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30409689      PMCID: PMC6295242          DOI: 10.1016/j.whi.2018.09.005

Source DB:  PubMed          Journal:  Womens Health Issues        ISSN: 1049-3867


  6 in total

1.  Trust and Mistrust in Shaping Adaptation and De-Implementation in the Context of Changing Screening Guidelines.

Authors:  Rachel C Shelton; Laura E Brotzman; Detric Johnson; Deborah Erwin
Journal:  Ethn Dis       Date:  2021-01-21       Impact factor: 1.847

2.  Effects of Prior Exposure to Conflicting Health Information on Responses to Subsequent Unrelated Health Messages: Results from a Population-Based Longitudinal Experiment.

Authors:  Rebekah H Nagler; Rachel I Vogel; Sarah E Gollust; Marco C Yzer; Alexander J Rothman
Journal:  Ann Behav Med       Date:  2022-05-18

3.  Why Was the US Preventive Services Task Force's 2009 Breast Cancer Screening Recommendation So Objectionable? A Historical Analysis.

Authors:  Barron H Lerner; Graham Curtiss-Rowlands
Journal:  Milbank Q       Date:  2022-09-23       Impact factor: 6.237

4.  Effects of Media Exposure to Conflicting Information About Mammography: Results From a Population-based Survey Experiment.

Authors:  Rebekah H Nagler; Marco C Yzer; Alexander J Rothman
Journal:  Ann Behav Med       Date:  2019-08-29

5.  How do patients and the public understand overtesting and overdiagnosis? A protocol for a thematic meta-synthesis of qualitative research.

Authors:  Tomas Rozbroj; Romi Haas; Denise A O'Connor; Rae Thomas; Kirsten McCaffery; Stacy Carter; Rachelle Buchbinder
Journal:  BMJ Open       Date:  2020-07-06       Impact factor: 2.692

6.  Prevalence and Potential Consequences of Exposure to Conflicting Information about Mammography: Results from Nationally-Representative Survey of U.S. Adults.

Authors:  Sarah E Gollust; Erika Franklin Fowler; Rebekah H Nagler
Journal:  Health Commun       Date:  2021-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.